KR20190120263A - 니코틴-함유 투명 경피 치료 시스템 - Google Patents

니코틴-함유 투명 경피 치료 시스템 Download PDF

Info

Publication number
KR20190120263A
KR20190120263A KR1020197027049A KR20197027049A KR20190120263A KR 20190120263 A KR20190120263 A KR 20190120263A KR 1020197027049 A KR1020197027049 A KR 1020197027049A KR 20197027049 A KR20197027049 A KR 20197027049A KR 20190120263 A KR20190120263 A KR 20190120263A
Authority
KR
South Korea
Prior art keywords
layer
nicotine
matrix
treatment system
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020197027049A
Other languages
English (en)
Korean (ko)
Inventor
토마스 힐레
가브리엘 바우어
페트라 보쳄
프랑크 자이베르츠
Original Assignee
에르테에스 로만 테라피-시스테메 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에르테에스 로만 테라피-시스테메 아게 filed Critical 에르테에스 로만 테라피-시스테메 아게
Publication of KR20190120263A publication Critical patent/KR20190120263A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J7/00—Adhesives in the form of films or foils
    • C09J7/30—Adhesives in the form of films or foils characterised by the adhesive composition
    • C09J7/38—Pressure-sensitive adhesives [PSA]
    • C09J7/381—Pressure-sensitive adhesives [PSA] based on macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C09J7/385—Acrylic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020197027049A 2017-02-27 2018-02-26 니코틴-함유 투명 경피 치료 시스템 Withdrawn KR20190120263A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017104026.9 2017-02-27
DE102017104026.9A DE102017104026A1 (de) 2017-02-27 2017-02-27 Nicotin enthaltendes transparentes transdermales therapeutisches System
PCT/DE2018/100168 WO2018153413A1 (de) 2017-02-27 2018-02-26 Nicotin enthaltendes transparentes transdermales therapeutisches system

Publications (1)

Publication Number Publication Date
KR20190120263A true KR20190120263A (ko) 2019-10-23

Family

ID=61837471

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197027049A Withdrawn KR20190120263A (ko) 2017-02-27 2018-02-26 니코틴-함유 투명 경피 치료 시스템

Country Status (12)

Country Link
US (1) US11964060B2 (enExample)
EP (1) EP3585440B1 (enExample)
JP (1) JP7149951B2 (enExample)
KR (1) KR20190120263A (enExample)
CN (1) CN110325216A (enExample)
AU (1) AU2018226365A1 (enExample)
CA (1) CA3051150C (enExample)
DE (1) DE102017104026A1 (enExample)
ES (1) ES2897449T3 (enExample)
MX (1) MX2019009781A (enExample)
RU (1) RU2019127802A (enExample)
WO (1) WO2018153413A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102477604B1 (ko) 2022-07-02 2022-12-14 주식회사 아이써치마케팅 온라인 마케팅 빅데이터 분석 시스템
KR102477606B1 (ko) 2022-07-02 2022-12-14 주식회사 아이써치마케팅 Sns 빅데이터 분석 시스템

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019117310A1 (de) * 2019-06-27 2020-12-31 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Wirkstoffverabreichungssystemen mittels Tampondruckverfahren

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59196817A (ja) 1983-04-21 1984-11-08 Sekisui Chem Co Ltd 貼付剤
DE3727232A1 (de) 1987-08-14 1989-02-23 Lohmann Therapie Syst Lts Verfahren zur herstellung einer darreichungs- und/oder dosierungsform fuer arzneimittelwirkstoffe
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4908213A (en) 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
DE4400769C2 (de) 1994-01-13 1996-07-18 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zur Herstellung einer flächigen Darreichungsform mit einer Arzneimittelwirkstoffe enthaltenden Zubereitung
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
ES2252865T3 (es) 1997-09-26 2006-05-16 Noven Pharmaceuticals, Inc. Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
DE69941629D1 (de) * 1998-12-18 2009-12-17 Alza Corp Durchsichtige transdermale nicotinabgabevorrichtungen
DE19912477A1 (de) * 1999-03-19 2000-09-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System und Verfahren zu seiner Herstellung
MXPA02005292A (es) 1999-11-29 2002-12-11 Lohmann Therapie Syst Lts Sistemas terapeuticos transdermicos que tienen estabilidad mejorada y su produccion.
US6479076B2 (en) 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
RU2263503C1 (ru) 2004-04-23 2005-11-10 Каш Тенгиз Способ получения препарата и препарат для трансдермального введения никотина
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
JP5000910B2 (ja) 2006-03-29 2012-08-15 リンテック株式会社 貼付剤及びその製造方法
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
RU2320674C1 (ru) 2006-07-12 2008-03-27 Каш Тенгис Способ получения сополимера n-винилпирролидона с лаурилметакрилатом для трансдермального введения никотина, сополимер, полученный этим способом, гель для трансдермального введения никотина
RU2356553C2 (ru) 2007-04-06 2009-05-27 Каш Тенгис Способ получения препарата и препарат для трансдермального введения никотина
PT2293786E (pt) 2008-05-21 2015-02-25 Novartis Ag Gomas de mascar que podem ser transformadas em comprimidos compreendendo nicotina e um agente tampão
GB201100790D0 (en) 2011-01-18 2011-03-02 Kraft Foods Global Brands Llc Hydrophilic gum base
JP5725940B2 (ja) * 2011-04-01 2015-05-27 日東電工株式会社 ニコチン含有貼付製剤
US20160199316A1 (en) * 2013-06-14 2016-07-14 Tesa Labtec Gmbh Three-layer transdermal therapy system (tts)
DE102014000200A1 (de) 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102477604B1 (ko) 2022-07-02 2022-12-14 주식회사 아이써치마케팅 온라인 마케팅 빅데이터 분석 시스템
KR102477606B1 (ko) 2022-07-02 2022-12-14 주식회사 아이써치마케팅 Sns 빅데이터 분석 시스템

Also Published As

Publication number Publication date
JP7149951B2 (ja) 2022-10-07
AU2018226365A1 (en) 2019-08-22
CA3051150C (en) 2023-10-03
WO2018153413A1 (de) 2018-08-30
EP3585440B1 (de) 2021-09-01
MX2019009781A (es) 2019-10-14
CA3051150A1 (en) 2018-08-30
CN110325216A (zh) 2019-10-11
EP3585440A1 (de) 2020-01-01
JP2020518553A (ja) 2020-06-25
ES2897449T3 (es) 2022-03-01
DE102017104026A1 (de) 2018-08-30
BR112019017151A2 (pt) 2020-04-14
RU2019127802A (ru) 2021-03-29
US20200230074A1 (en) 2020-07-23
US11964060B2 (en) 2024-04-23
RU2019127802A3 (enExample) 2021-03-29

Similar Documents

Publication Publication Date Title
JP6083734B2 (ja) リバスチグミンまたはその誘導体を投与するための経皮治療システム
DK2468274T3 (en) Transdermal therapeutic system for administration of an active substance
RU2481826C2 (ru) Содержащий донепезил адгезивный препарат и упаковка для него
US20200009073A1 (en) Fibre-Free Transdermal Therapeutic System and Method for its Production
US20140083878A1 (en) Transdermal drug delivery device
HUE035312T2 (en) Pharmaceutical patch (1R, 4R) -6'-fluoro-N, N-dimethyl-4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'-pyrano [3,4- b] for transdermal administration of indole] -4-amine
KR20060120678A (ko) 남용될 가능성이 감소된 경피용 진통제 시스템
NO180107B (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system med physostigmin som virkestoff
KR20120107153A (ko) 펜타닐 경피 패치제
CA2692364C (en) Reservoir system comprising a closed membrane
KR20130042520A (ko) 니코틴 경피 전달 시스템
IL157692A (en) Method for the manufacture of transdermal therapeutic system with nicotine content
KR20190120263A (ko) 니코틴-함유 투명 경피 치료 시스템
US5705186A (en) Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide
HK40012583B (en) Nicotine-containing transparent transdermal therapeutic system
HK40012583A (en) Nicotine-containing transparent transdermal therapeutic system
BR112019017151B1 (pt) Sistema terapêutico transdérmico, método para produzir o mesmo, uso de um polímero e método para estabilizar nicotina
AU2002247331C1 (en) Transdermal patch for administering fentanyl
HK1187247A (en) Transdermal therapeutic system for administering an active substance
HK1187247B (en) Transdermal therapeutic system for administering an active substance

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190917

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201027

Comment text: Request for Examination of Application

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20210610

WITB Written withdrawal of application